US Bancorp’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $7.04M | Buy |
32,597
+1,374
| +4% | +$263K | 0.01% | 523 |
|
|
2026
Q1 | $5.72M | Buy |
31,223
+4,466
| +17% | +$823K | 0.01% | 543 |
|
|
2025
Q4 | $4.71M | Buy |
26,757
+5,324
| +25% | +$870K | 0.01% | 620 |
|
|
2025
Q3 | $3M | Buy |
21,433
+4,324
| +25% | +$584K | ﹤0.01% | 748 |
|
|
2025
Q2 | $2.15M | Sell |
17,109
-8,837
| -34% | -$1.1M | ﹤0.01% | 833 |
|
|
2025
Q1 | $3.55M | Buy |
25,946
+6,743
| +35% | +$964K | ﹤0.01% | 668 |
|
|
2024
Q4 | $2.94M | Sell |
19,203
-1,011
| -5% | -$171K | ﹤0.01% | 737 |
|
|
2024
Q3 | $3.92M | Sell |
20,214
-3,755
| -16% | -$786K | 0.01% | 643 |
|
|
2024
Q2 | $5.56M | Buy |
23,969
+6,393
| +36% | +$1.39M | 0.01% | 551 |
|
|
2024
Q1 | $3.79M | Sell |
17,576
-2,648
| -13% | -$620K | 0.01% | 647 |
|
|
2023
Q4 | $5.23M | Sell |
20,224
-680
| -3% | -$167K | 0.01% | 560 |
|
|
2023
Q3 | $5.37M | Sell |
20,904
-2,480
| -11% | -$663K | 0.01% | 533 |
|
|
2023
Q2 | $6.66M | Sell |
23,384
-893
| -4% | -$266K | 0.01% | 497 |
|
|
2023
Q1 | $6.75M | Sell |
24,277
-1,753
| -7% | -$485K | 0.01% | 490 |
|
|
2022
Q4 | $7.21M | Buy |
26,030
+1,742
| +7% | +$492K | 0.01% | 471 |
|
|
2022
Q3 | $6.48M | Sell |
24,288
-2,197
| -8% | -$467K | 0.01% | 463 |
|
|
2022
Q2 | $5.4M | Sell |
26,485
-3,746
| -12% | -$766K | 0.01% | 516 |
|
|
2022
Q1 | $6.37M | Sell |
30,231
-6,006
| -17% | -$1.31M | 0.01% | 515 |
|
|
2021
Q4 | $8.7M | Sell |
36,237
-9,593
| -21% | -$2.47M | 0.01% | 453 |
|
|
2021
Q3 | $13M | Sell |
45,830
-2,234
| -5% | -$732K | 0.02% | 352 |
|
|
2021
Q2 | $16.6M | Sell |
48,064
-10,560
| -18% | -$3.2M | 0.03% | 319 |
|
|
2021
Q1 | $16.4M | Sell |
58,624
-1,612
| -3% | -$435K | 0.03% | 311 |
|
|
2020
Q4 | $14.7M | Sell |
60,236
-6,325
| -10% | -$1.63M | 0.03% | 315 |
|
|
2020
Q3 | $18.9M | Sell |
66,561
-5,004
| -7% | -$1.4M | 0.05% | 265 |
|
|
2020
Q2 | $19.1M | Sell |
71,565
-3,587
| -5% | -$1.08M | 0.05% | 259 |
|
|
2020
Q1 | $23.8M | Sell |
75,152
-14,230
| -16% | -$4.32M | 0.07% | 201 |
|
|
2019
Q4 | $26.5M | Sell |
89,382
-26,786
| -23% | -$7.43M | 0.07% | 213 |
|
|
2019
Q3 | $27M | Sell |
116,168
-10,700
| -8% | -$2.49M | 0.07% | 210 |
|
|
2019
Q2 | $29.7M | Sell |
126,868
-34,914
| -22% | -$8.06M | 0.08% | 194 |
|
|
2019
Q1 | $38.2M | Sell |
161,782
-903
| -0.6% | -$284K | 0.11% | 167 |
|
|
2018
Q4 | $49M | Buy |
162,685
+6,571
| +4% | +$2.1M | 0.16% | 129 |
|
|
2018
Q3 | $55.2M | Sell |
156,114
-10,651
| -6% | -$3.67M | 0.16% | 126 |
|
|
2018
Q2 | $48.4M | Buy |
166,765
+1,464
| +0.9% | +$412K | 0.15% | 136 |
|
|
2018
Q1 | $45.3M | Buy |
165,301
+10,057
| +6% | +$3.12M | 0.14% | 144 |
|
|
2017
Q4 | $49.5M | Buy |
155,244
+4,706
| +3% | +$1.51M | 0.15% | 136 |
|
|
2017
Q3 | $47.1M | Buy |
150,538
+17,172
| +13% | +$5.08M | 0.15% | 132 |
|
|
2017
Q2 | $36.2M | Buy |
133,366
+7,322
| +6% | +$1.94M | 0.12% | 153 |
|
|
2017
Q1 | $34.5M | Sell |
126,044
-2,875
| -2% | -$813K | 0.12% | 160 |
|
|
2016
Q4 | $36.6M | Buy |
128,919
+3,388
| +3% | +$1M | 0.13% | 150 |
|
|
2016
Q3 | $39.3M | Buy |
125,531
+8,044
| +7% | +$2.38M | 0.15% | 136 |
|
|
2016
Q2 | $28.4M | Buy |
117,487
+28,709
| +32% | +$7.57M | 0.11% | 167 |
|
|
2016
Q1 | $23.1M | Buy |
88,778
+17,635
| +25% | +$4.66M | 0.09% | 192 |
|
|
2015
Q4 | $21.8M | Buy |
71,143
+2,076
| +3% | +$597K | 0.09% | 193 |
|
|
2015
Q3 | $20.2M | Buy |
69,067
+9,213
| +15% | +$3.04M | 0.08% | 205 |
|
|
2015
Q2 | $24.2M | Buy |
59,854
+3,872
| +7% | +$1.55M | 0.09% | 195 |
|
|
2015
Q1 | $23.6M | Buy |
55,982
+3,163
| +6% | +$1.25M | 0.09% | 192 |
|
|
2014
Q4 | $17.9M | Buy |
52,819
+11,231
| +27% | +$3.63M | 0.07% | 229 |
|
|
2014
Q3 | $13.8M | Buy |
41,588
+4,192
| +11% | +$1.38M | 0.06% | 259 |
|
|
2014
Q2 | $11.8M | Buy |
37,396
+4,600
| +14% | +$1.38M | 0.05% | 285 |
|
|
2014
Q1 | $10M | Buy |
32,796
+10,393
| +46% | +$3.3M | 0.04% | 309 |
|
|
2013
Q4 | $6.26M | Buy |
22,403
+7,225
| +48% | +$1.87M | 0.03% | 374 |
|
|
2013
Q3 | $3.65M | Sell |
15,178
-1,167
| -7% | -$261K | 0.02% | 473 |
|
|
2013
Q2 | $3.52M | Buy |
+16,345
| New | +$3.49M | 0.02% | 454 |
|
Other funds holding BIIB
US Bancorp's BIIB Position: Q2 2026 in Review
US Bancorp increased its Biogen (BIIB) stake by 4.4% in Q2 2026, buying an estimated $263K and bringing the position to 32,597 shares worth $7.04M. The position accounts for 0.01% of the portfolio, ranked #523.
US Bancorp first reported a position in BIIB in Q2 2013 and has held it in 53 quarters since. The position peaked at $55.2M in Q3 2018. 1,036 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- US Bancorp held 32,597 shares of Biogen worth $7.04M as of Q2 2026.
- US Bancorp bought 1,374 Biogen shares in Q2 2026, an estimated $263K.
- Biogen made up 0.01% of US Bancorp's portfolio in Q2 2026, its #523 holding.
- US Bancorp first reported a position in Biogen in Q2 2013 and has held it in 53 quarters since.
- US Bancorp's Biogen position peaked at $55.2M in Q3 2018.
- 1,036 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.